According to Nykode Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.24. In 2022 the company made an earnings per share (EPS) of -HK$1.09 a decrease over its 2021 EPS that were of -HK$0.23.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$1.25 | 15.14% |
2022 | -HK$1.09 | 366.67% |
2021 | -HK$0.23 |